<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS NINE MONTH YEAR TO DATE SUMMARY FINANCIAL INFORMATION
EXTRACTED FROM AMERICAN BIOGENETIC SCIENCES, INC. 2000 10-Q FOR THE THIRD
QUARTER ENDED SEPTEMBER 30, 2000.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-END> SEP-30-2000
<CASH> 2,083,000
<SECURITIES> 0
<RECEIVABLES> 340,000
<ALLOWANCES> 0
<INVENTORY> 562,000
<CURRENT-ASSETS> 54,000
<PP&E> 2,346,000
<DEPRECIATION> 1,919,000
<TOTAL-ASSETS> 6,170,000
<CURRENT-LIABILITIES> 483,000
<BONDS> 0
0
0
<COMMON> 44,000
<OTHER-SE> 5,630,000
<TOTAL-LIABILITY-AND-EQUITY> 6,170,000
<SALES> 1,211,000
<TOTAL-REVENUES> 1,853,000
<CGS> 447,000
<TOTAL-COSTS> 447,000
<OTHER-EXPENSES> 940,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 16,000
<INCOME-PRETAX> (2,529,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,529,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,529,000)
<EPS-BASIC> (.12)
<EPS-DILUTED> (.12)
</TABLE>